Active Shortage Tablet Psychiatry

Amphetamine Aspartate Monohy · #22 of 35 active shortages by FDA posting duration

Name: FDA Drug Shortage: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
Creator: PlainMeds
License: https://plainmeds.com/terms

Compiled by PlainMeds, Drug Information Editorial Process

Brand: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

FDA lists Amphetamine Aspartate Monohy as Active Shortage (Sandoz Inc.).

Availability on file: Limited Availablity

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet: Active Shortage

Limited Availablity 73 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.

Shortage Details

Generic Name: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
Manufacturer: Sandoz Inc.
Dosage Form: Tablet
Presentation: Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01)
Package NDC: 0185-2099-01

Status & Timeline

Status: Active Shortage
Availability: Limited Availablity
First Reported: Oct 12, 2022
Last Updated: Mar 19, 2026
Therapeutic Category: Psychiatry

Row fields from the FDA Drug Shortages database via openFDA.

Shortage Reason

Intermittent backorders in 1Q2026 and 2Q2026

Full Drug Profile

amphetamine/dextroamphetamine

Side effects, interactions, warnings & more

View Profile

Compare amphetamine/dextroamphetamine with alternatives →